t.malinowski
Submits third-party assay reports on material purchased directly. Based in Mombasa.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.44%
n=8
Suppliers covered
6
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043012 | L-Glutathione (reduced) | MKM | MKM-2602-X4844 | PeptideMeter | 2026-Q2 | 98.68 | 8.77 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020674 | Afamelanotide | SGN | SGN-2510-R8306 | Janoshik | 2025-Q4 | 98.22 | 5.36 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018862 | KPV | FGP | FGP-2506-L8855 | Kestrel | 2025-Q3 | 99.84 | 4.04 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-020581 | Tirzepatide | SSA | SSA-2502-D7226 | Janoshik | 2025-Q3 | 97.83 | 6.53 | 96.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018891 | Semaglutide | TFS | TFS-{CAT}-9459 | Janoshik | 2025-Q2 | 98.60 | 3.54 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004953 | Retatrutide | GGPeps | GGPE-2404-K2899 | Janoshik | 2024-Q3 | 97.83 | 4.57 | 103.8 | Buyer-sourced | 0 | PASS |
| AX-2024-005153 | Tirzepatide | SGN | SGN-2401-K9783 | PeptideMeter | 2024-Q2 | 98.29 | 4.42 | 98.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004348 | TB-500 | FGP | FGP-2402-X8147 | Janoshik | 2024-Q2 | 99.71 | 5.22 | 103.8 | Buyer-sourced | 1 | MARGINAL |